* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : genetics;

True Meta (CISMeF) : O;

Details


Main resources

You can consult :


https://publications.msss.gouv.qc.ca/msss/document-003698/
2024
Canada
scientific and technical information
algorithms
genets
genetics
gene, nos
Clinical Trial Eligibility Criteria
mars
Genetic Testing
Handbook
insurance
Interpretation
genetta, nos
cytisus
interpreter
Department
March
Software Service
Guide Device
viverridae
Algorithm

---
https://www.cochrane.org/fr/CD002203/CF_traitement-par-antibiotiques-macrolides-y-compris-lazithromycine-pour-les-personnes-atteintes-de
2024
false
true
false
United Kingdom
France
treatment outcome
azithromycin
infant, newborn
adult
child
pseudomonas aeruginosa
pseudomonas infections
meta-analysis
french abstract
macrolides
cystic fibrosis
anti-bacterial agents

---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related

---
https://www.health.belgium.be/fr/avis-9801-nouvelles-techniques-genomiques-ngts
2024
Belgium
technical report
Tumor Necrosis Factor Ligand Superfamily Member 15
proposita
Middle
genome, nos
Moderately Bothered
Medium Heart Murmur
genome
Some
Adverse Event Definitely Related to Intervention
A Medium Amount of Time
Middle Lobe of the Prostate
Medium Growth Rate
plants
Technique
Genome
social control, formal
Media
genomics
Proposal
TNFSF15 wt Allele
Certain
Growth Medium

---
https://ansm.sante.fr/actualites/decision-du-21-03-2024-cadre-de-prescription-compassionnelle-de-tacrolimus-0-1-pommade
2024
false
false
false
France
French
drug information
tacrolimus
administration, cutaneous
ointments
legislation, pharmacy
adult
child
adolescent
vitiligo
tacrolimus

---
https://ansm.sante.fr/tableau-acces-derogatoire/tacrolimus#
2024
false
false
false
France
French
tacrolimus
drug information
administration, cutaneous
vitiligo

---
Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous Adverse Reactions
https://recalls-rappels.canada.ca/fr/avis-rappel/ezetrol-ezetimibe-et-risques-lesions-hepatiques-origine-medicamenteuse-et-reactions
2024
false
false
false
Canada
French
English
pharmacovigilance note
Ezetimibe
Chemical and Drug Induced Liver Injury
Drug-Induced Liver Disease
drug hypersensitivity syndrome
stevens-johnson syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
canada
administration, oral
ezetimibe
anticholesteremic agents

---
https://www.has-sante.fr/jcms/p_3505740/fr/lojuxta-lomitapide-hypercholesterolemie-familiale-homozygote
2024
false
false
false
France
Lomitapide Mesylate
Homozygous Familial Hypercholesterolemia
child
adolescent
evaluation of the transparency committee
lomitapide
Lomitapide Mesylate
mesylates

---
https://www.reseau-naissance.fr/medias/2016/12/Protocole-PEC-nne-de-mere-sous-opiaces-pendant-la-grossesse.pdf
2024
France
guideline
opioid withdrawal
newborn, nos
New Lesion Identification
Newar Language
infant, newborn
health planning guidelines
charge association
CHARGE Syndrome
mother, nos
Maternal
Maternal Relative
patient care management
CHARGE syndrome
substance withdrawal syndrome
Opiate Withdrawal Syndrome

---
https://www.has-sante.fr/jcms/p_3471694/fr/orkambi-lumacaftor/ivacaftor-mucoviscidose
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
lumacaftor, ivacaftor drug combination
drug combinations
ivacaftor
lumacaftor
ivacaftor and lumacaftor
infant
administration, oral
evaluation of the transparency committee
cystic fibrosis

---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense

---
https://www.has-sante.fr/jcms/p_3471037/fr/
2024
France
health technology assessment
genome, nos
Early Stage Breast Carcinoma
breast cancer
Useful
hospitals, proprietary
Clinical Data
Signature
Genome
early
Clinical Lot
breast neoplasms
Ambulatory Care Facility
neoplasm staging
genomics
Clinical Batch
genome
neoplasm, malignant

---
https://www.has-sante.fr/jcms/p_3478096/fr/kalydeco-ivacaftor-mucoviscidose
2024
false
false
false
France
infant
child
evaluation of the transparency committee
ivacaftor
cystic fibrosis
ivacaftor
Ivacaftor
Cystic Fibrosis
cystic fibrosis
kalydeco
ivacaftor

---
https://ansm.sante.fr/tableau-marr/inhibiteur-de-la-c1-esterase-humaine
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
Human C1-Esterase Inhibitor
patients guideline

---
https://www.usherbrooke.ca/baladocritique/archives/episode-59-etude-select
2024
Canada
sound
Diastolic Blood Pressure
semaglutide
Obesity, CTCAE
Cardiovascular Disorder
data collection
Off Study
obesity
disease of cardiovascular system, nos
breeding
Clinical Study
semaglutide
obesity
Obesity
Have Diabetes
Human Participant Protection Regulations
DICOM Study
obesity, nos
cardiovascular diseases
diabetes mellitus
persons
Semaglutide
Obese
On Study

---
https://www.has-sante.fr/jcms/p_3490824/fr/crysvita-burosumab-hypophosphatemie-liee-a-l-x
2024
false
false
false
France
child
adolescent
treatment outcome
insurance, health, reimbursement
rickets, X-Linked hypophosphatemic
burosumab
injections, subcutaneous
antibodies, monoclonal, humanized
evaluation of the transparency committee
burosumab
familial hypophosphatemic rickets
X-Linked Dominant Hypophosphatemic Rickets

---
https://www.has-sante.fr/jcms/p_3426280/fr/depistage-neonatal-reevaluation-de-l-opportunite-d-integrer-cinq-erreurs-innees-du-metabolisme-au-programme-de-dnn
2024
France
public health guidelines
Newborn Screening
Schedule
metabolic disease, nos
Integrator Device
Integrated
neonatal screening, nos
metabolism, inborn errors
neonatal screening
Severity One Out of Five
Congenital Metabolic Disorder
Scheduled
Metabolic Programming

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-de-lajout-du-depistage-neonatal-de-lhyperplasie-congenitale-des-surrenales-au-programme-quebecois-de-depistage-neonatal-sanguin.html
2024
Canada
review of literature
public health guidelines
Add
Attention Deficit Hyperactivity Disorder, Inattentive Type
Schedule
congenital adrenal cortical hyperplasia, nos
adrenal hyperplasia, congenital
Program
neonatal screening, nos
Newborn Screening
neonatal screening
Congenital Adrenal Hyperplasia
Blood Screening
Scheduled

---
https://www.has-sante.fr/jcms/p_3449778/fr/crysvita-burosumab-hypophosphatemie-liee-au-fgf23
2024
false
false
false
France
French
evaluation of the transparency committee
burosumab

---
https://www.has-sante.fr/jcms/p_3495394/fr/takhzyro-lanadelumab-angioedeme-hereditaire
2024
false
false
false
France
French
insurance, health, reimbursement
lanadelumab
evaluation of the transparency committee
child
angioedemas, hereditary
Hereditary angioedema attack
lanadelumab
treatment outcome
guidelines for drug use
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)

---
https://www.has-sante.fr/jcms/p_3498146/fr/myozyme-alglucosidase-alfa-maladie-de-pompe-deficit-en-glucosidase-acide
2024
false
false
false
France
GAA protein, human
adult
adolescent
child
treatment outcome
insurance, health, reimbursement
enzyme replacement therapy
infusions, intravenous
alglucosidase alfa
glycogen storage disease type II, infantile
adult glycogen storage disease type II
Glycogen storage disease type II late onset (disorder)
evaluation of the transparency committee
glycogen storage disease type ii
alglucosidase alfa

---
https://www.has-sante.fr/jcms/p_3498741/fr/takhzyro-lanadelumab-angiooedeme-hereditaire
2024
false
false
false
France
antibodies, monoclonal, humanized
treatment outcome
insurance, health, reimbursement
angioedemas, hereditary
child
lanadelumab
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)
Hereditary angioedema attack
evaluation of the transparency committee
lanadelumab

---
https://ansm.sante.fr/tableau-acces-derogatoire/upstaza
2024
false
false
false
France
French
Eladocagene Exuparvovec
drug information
infant
Aromatic-L-Amino-Acid decarboxylases
Aromatic-L-Amino-Acid Decarboxylase
aromatic amino acid decarboxylase deficiency

---
https://ansm.sante.fr/tableau-acces-derogatoire/kaftrio-75-mg-50-mg-100-mg-comprime-pellicule-kalydeco-150-mg-comprime-pellicule
2024
false
false
false
France
French
cystic fibrosis
guidelines for drug use
continuity of patient care
drug therapy, combination
administration, oral
ivacaftor, tezacaftor and elexacaftor
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
tezacaftor
elexacaftor
adult
adolescent
ivacaftor
trikafta
drug combinations
drug information

---
https://www.has-sante.fr/jcms/p_3499784/fr/prolastin-alpha-1-antitrypsine-humaine-deficit-en-alpha-1-antitrypsine
2024
false
false
false
France
insurance, health, reimbursement
alfa1 antitrypsin
alpha 1-Antitrypsin
alpha 1-antitrypsin deficiency
Product containing only human alpha1 proteinase inhibitor in parenteral dose form (medicinal product form)
evaluation of the transparency committee

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panels-de-la-deficience-intellectuelle-et-du-retard-global-du-developpement-par-sequencage-de-nouvelle-generation.html
2023
Canada
review of literature
intellectual disability
developmental disabilities
child development disorders, specific
family characteristics
sequence determinations
Intellectual deficiency
failure to thrive
impairment
Intellectual deficiency
generations
Intellectual deficiency
Intellectual deficiency
Intellectual deficiency
sequence analysis

---
https://www.has-sante.fr/jcms/p_3418145/fr/livmarli-maralixibat-syndrome-d-alagille
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
maralixibat chloride
infant
child
Cholestatic pruritus (disorder)
administration, oral
orphan drug production
evaluation of the transparency committee
maralixibat
alagille syndrome

---
https://ansm.sante.fr/tableau-marr/eladocagene-exuparvovec
2023
false
false
false
France
French
risk management
guidelines for drug use
Eladocagene Exuparvovec
drug compounding
Stereotactic surgery
stereotaxic techniques
gene therapy
Intraputaminal Route of Administration
aromatic amino acid decarboxylase deficiency
Injection of brain (procedure)
infusions, parenteral
neurosurgical procedures
patient education handout
guideline
eladocagene exuparvovec

---
https://www.sf2h.net/publications/recommandations-relatives-aux-indications-du-diagnostic-de-la-covid-19.html
2023
false
false
false
France
molecular biology
guideline
COVID-19
hospitals

---
https://www.cochrane.org/fr/CD013733/CF_les-technologies-numeriques-aident-elles-les-personnes-atteintes-de-mucoviscidose-respecter-leurs
2023
United Kingdom
review of literature
french abstract
inspiration
cystic fibrosis
administration, inhalation
cystic fibrosis
Cystic fibrosis
patient compliance
Technology
persons
disease
technology
Respect
inhalers

---
https://www.has-sante.fr/jcms/p_3403913/fr/atteinte-pulmonaire-associee-a-un-deficit-en-alpha1-antitrypsine
2023
false
false
false
France
alpha 1-antitrypsin deficiency
lung diseases
alpha 1-antitrypsin deficiency
alpha 1-antitrypsin deficiency
practice guideline

---
https://www.sfdiabete.org/sites/www.sfdiabete.org/files/files/ressources/1-s2.0-s1957255723000159-main.pdf
2023
false
false
false
France
Glucose intolerance
glucose intolerance
Cystic fibrosis related diabetes
practice guideline
cystic fibrosis
diabetes mellitus

---
https://apps.who.int/iris/handle/10665/366577
2023
false
false
false
Switzerland
journal article
blood group antigen m1a
blood group antigen hg a
blood group antigen pr a
genetta, nos
blood group antigen ok a
blood group antigen r1a
blood group antigen sd a
blood group antigen jk a
blood group antigen kp a
Genetics
blood group antigen fr a
blood group antigen at a
blood group antigen yh a
blood group antigen tg a
blood group antigen fy a
blood group antigen jc a
blood group antigen en ats
Viruses
blood group antigen le d
blood group antigen u1a
blood group antigen a.m.
blood group antigen ch a
blood group antigen sf a
blood group antigen cr3
blood group antigen li a
blood group antigen lan
blood group antigen in a
blood group antigen co a
blood group antigen tr a
antigen, nos
blood group antigen lu a
blood group antigen go a
blood group antigen th a
blood group antigen bp a
blood group antigen ht a
blood group antigen en afs
blood group antigen kn a
antigens
blood group antigen pt a
blood group antigen dh a
blood group antigen chr a
blood group antigen or a
blood group antigen jr a
genets
cytisus
Antigens
blood group antigen wk a
due to
blood group antigen pr a
blood group antigen ny a
blood group antigen s1a
blood group antigen dr a
blood group antigen cl a
blood group antigen le x
blood group antigen os a
blood group antigen bg a
blood group antigen le a
Genetics
blood group antigen c
blood group antigen en afr
blood group antigen le c
blood group antigen au a
viverridae
blood group antigen a1 le d
blood group antigen en akt
blood group antigen le b
blood group antigen sk a
blood group antigen rg a
blood group antigen yt a
blood group antigen a1b
blood group antigen vr
blood group antigen le bh
blood group antigen rd a
blood group antigen a1 le b
blood group antigen a.m.
blood group antigen le s
Virus
viruses
blood group antigen sc2
blood group antigen ls a
blood group antigen a2b
blood group antigen to a
Preparation
blood group antigen n a
blood group antigen an a
blood group antigen lw b
blood group antigen ol a
blood group antigen vg a
gene, nos
blood group antigen sw a
blood group antigen jo a
blood group antigen cs a
blood group antigen ri a
blood group antigen wd a
blood group antigen do a
blood group antigen m a
blood group antigen er a
blood group antigen es a
blood group antigen rb a
blood group antigen a3b
blood group antigen wr a
blood group antigen zt a
blood group antigen di a
blood group antigen mi a
blood group antigen lw a
blood group antigen nijhuis
blood group antigen bx a
Genetics
blood group antigen st a
blood group antigen be a
blood group antigen re a
blood group antigen mt a
blood group antigen mo a
blood group antigen xg a
blood group antigen yk a
blood group antigen c
virus, nos
pandemics
blood group antigen rh a
blood group antigen a3
blood group antigen gy a
blood group antigen 'n'
blood group antigen jn a
blood group antigen js a
blood group antigen mcc a
blood group antigen a2
blood group antigen rh42
blood group antigen a x
blood group antigen le ns
blood group antigen m'
blood group antigen je a
blood group antigen tj a
blood group antigen le bl
genetics

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-neonatal-sanguin-par-spectrometrie-de-masse-en-tandem-derreurs-innees-du-metabolisme-asa-ga1-lchadd-tfpd-vlcadd.html
2023
Canada
technical report
Mass spectrometry
neonatal screening, nos
tandem mass spectrometry
metabolism, inborn errors
blood volume, nos
mass screening
aspirin
metabolic disease, nos
Metabolism
neonatal screening

---
https://www.enfant-encyclopedie.com/hyperactivite-et-inattention-tdah/selon-experts/les-contributions-genetiques-au-tdah
2023
Canada
scientific and technical information
Genetics
cytisus
genetics
attention deficit disorder with hyperactivity
Genetics
viverridae
gene, nos
genets
genetta, nos
Genetics

---
https://ansm.sante.fr/tableau-marr/alglucosidase-alpha
2023
false
false
false
France
French
guidelines for drug use
risk management
alpha-Glucosidases
alpha-Glucosidases
alpha-Glucosidases

---
https://www.has-sante.fr/jcms/p_3427763/fr/bylvay-odevixibat-prurit-cholestatique-associe-au-syndrome-d-alagille
2023
false
false
false
France
cholestatic pruritus in Alagille syndrome
infant
child
guidelines for drug use
treatment outcome
insurance, health, reimbursement
administration, oral
odevixibat
evaluation of the transparency committee
pruritus
alagille syndrome
odevixibat

---
https://interstices.info/le-sars-cov-2-une-experience-inedite-de-surveillance-genomique-mondiale/
2023
France
scientific and technical information
SARS-CoV-2
genome, nos
genomics
organization and administration

---
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Activite-des-plateformes-de-genetique-moleculaire-des-cancers-en-2019-2020-Rapport-d-activite
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Activite-des-plateformes-de-genetique-moleculaire-des-cancers-en-2019-2020-Synthese-du-rapport-d-activite
2023
France
technical report
albumin/globulin ratio
research report
Molecular genetics
Molecular genetics
gene, nos
genetics, molecular
molecular biology

---
https://ansm.sante.fr/tableau-marr/elosulfase-alfa
2023
false
false
false
France
French
guidelines for drug use
risk management
elosulfase alfa
elosulfase alfa
infusions, intravenous
infusion rate
drug dosage calculations

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-dajouter-les-variantes-hbs-e-hbe-e-et-hbe-b-thal-aux-cibles-primaires-du-test-de-depistage-neonatal-des-hemoglobinopathies.html
2023
Canada
public health guidelines
hemoglobinopathy, nos
hemoglobinopathies
principal
neonatal screening, nos
Hemoglobinopathy
neonatal screening
dermatomyositis

---
https://dumas.ccsd.cnrs.fr/dumas-04061185
2023
France
Diseases
disease, nos
cystic fibrosis
cystic fibrosis
disease
Cystic fibrosis
Rare disease
rare diseases

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/principes-et-criteres-de-selection-des-genes-pour-le-diagnostic-moleculaire-des-maladies-en-genetique-constitutionnelle-par-sequencage-de-nouvelle-generation-sng.html
2023
Canada
technical report
Molecular genetics
policy
disease
family characteristics
generations
genetics, molecular
genetic selection
Genetic disease
principle-based ethics
nasogastric tube
pathology, molecular
Diseases
no diagnosis
selection, genetic
selection criteria
hereditary disease, nos
sequence analysis
genetic diseases, inborn
diagnosis
Molecular genetics
genes
patient selection
sequence determinations

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-5-mai-2023/comparaison-tests-utilises-programme-sras-cov-2-rcli.html
2023
Canada
journal article
nucleic acids
nucleic acid amplification, nos
reticulum
competence
nucleic acid amplification techniques
mental competency
Program
Nucleic acids
Severe acute respiratory syndrome-related coronavirus
auditor
competence
laboratories

---
https://ansm.sante.fr/tableau-marr/atidarsagene-autotemcel
2023
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
Atidarsagene Autotemcel
risk management
infusions, intravenous
gene therapy
atidarsagene autotemcel
biological products

---
https://ansm.sante.fr/tableau-marr/agalsidase-beta
2023
false
false
false
France
French
risk management
agalsidase beta
guidelines for drug use
patients guideline
infusions, intravenous
enzyme replacement therapy
fabry disease
continuity of patient care
home health nursing

---
https://ansm.sante.fr/tableau-marr/asfotase-alfa
2023
false
false
false
France
French
risk management
guidelines for drug use
asfotase alfa
asfotase alfa
self administration
patients guideline
child
injections, subcutaneous
enzyme replacement therapy
asfotase alfa
hypophosphatasia

---
https://publications.msss.gouv.qc.ca/msss/document-003344/
2023
false
false
false
Canada
handbooks
hereditary diseases
Diseases
metabolic diseases
metabolism, inborn errors
Metabolic diseases
Hereditary disease
Metabolic diseases
Metabolic diseases
metabolic disease, nos
Program
hereditary disease, nos
waiting lists

---
https://ansm.sante.fr/tableau-acces-derogatoire/nexviadyme-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2023
false
false
false
France
French
summary of product characteristics
package leaflet
infusions, intravenous
Avalglucosidase Alfa
glycogen storage disease type ii
guidelines for drug use

---
https://ansm.sante.fr/tableau-acces-derogatoire/oxbryta-voxelotor
2023
false
false
false
France
French
risk management
voxelotor
voxelotor
administration, oral
hematologic agents
drug information
anemia, hemolytic
anemia, sickle cell

---
https://ansm.sante.fr/tableau-marr/valproate-et-derives
2023
false
false
false
France
French
risk management
valproate
pregnancy
teratogens
valproate sodium
-
Divalproex Sodium
dipropylacetamide
pregnancy tests
contraception
guideline
patient education handout
forms
developmental disabilities
Contraindications, Drug
valproic acid
valproic acid

---
https://www.cochrane.org/fr/CD001401/CF_techniques-de-degagement-des-voies-respiratoires-comparees-labsence-de-techniques-de-degagement-des
2023
false
France
United Kingdom
French
review of literature
cystic fibrosis
respiratory therapy
treatment outcome
french abstract

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-5-mai-2023/tests-aptitude-sras-cov-2-reseau-canadien-intervention-laboratoire.html
2023
Canada
journal article
canada
laboratories
Essay
reticulum
Severe acute respiratory syndrome-related coronavirus
Program
nucleic acids
Nucleic acids
patient compliance
nucleic acid amplification techniques
aptitude
nucleic acid amplification, nos
observation

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pombiliti
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Cipaglucosidase Alfa
Cipaglucosidase Alfa
cipaglucosidase alfa
enzyme replacement therapy
glycogen storage disease type ii
Glycogen storage disease type II late onset (disorder)
drug therapy, combination
miglustat
infusions, intravenous
pregnancy
breast feeding
drug evaluation, preclinical
adult

---
https://www.cochrane.org/fr/CD002011/CF_la-kinesitherapie-respiratoire-conventionnelle-classique-comparee-dautres-methodes-de-degagement-des
2023
United Kingdom
review of literature
french abstract
respiratory system
Other methods
disease
cystic fibrosis
cystic fibrosis
Cystic fibrosis
protestantism
respiratory tract
physical therapy specialty
persons

---
https://www.has-sante.fr/jcms/p_3312530/fr/diagnostic-et-prise-en-charge-des-patients-adultes-avec-un-syndrome-post-reanimation-pics-et-de-leur-entourage
2023
France
practice guideline
adulthood
charge association
resuscitation
no diagnosis
case management
diagnosis
CHARGE syndrome
Adult
Propping Zerres syndrome
Adult
has patient
adult
CHARGE syndrome
propping zerres syndrome

---
https://www.has-sante.fr/jcms/p_3448025/fr/oxbryta-voxelotor-anemie-hemolytique
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
voxelotor
hematologic agents
anemia, sickle cell
adult
adolescent
summary of product characteristics
drug therapy, combination
evaluation of the transparency committee
voxelotor
anemia, hemolytic

---
https://www.has-sante.fr/jcms/p_3385532/fr/voxzogo-0-4-0-56-1-2-mg-vosoritide-achondroplasie
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
vosoritide
child
adolescent
evaluation of the transparency committee
achondroplasia
vosoritide

---
https://www.has-sante.fr/jcms/p_3446078/fr/diprosone-betamethasone-/-diprosalic-betamethasone-/-acide-salicylique-corticoides
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
administration, cutaneous
evaluation of the transparency committee
salicylic acid
corticoids
betamethasone
glucocorticoids

---
http://www.lecrat.eu/?s=Canakinumab+-+Grossesse+et+allaitement
2023
false
false
false
France
French
drug information
pregnancy
breast feeding
canakinumab

---
https://www.has-sante.fr/jcms/p_3448570/fr/vimizim-elosulfase-alfa-mucopolysaccharidose-de-type-iv-a-syndrome-de-morquio-a
2023
false
false
false
France
infusions, intravenous
treatment outcome
insurance, health, reimbursement
elosulfase alfa
mucopolysaccharidosis type IV A
enzyme replacement therapy
evaluation of the transparency committee
mucopolysaccharidosis IV
elosulfase alfa

---
https://ansm.sante.fr/actualites/lamotrigine-attention-au-risque-deruption-cutanee-grave-en-particulier-au-debut-du-traitement
2023
false
false
false
France
French
pharmacovigilance note
Lamotrigine
lamotrigine
drug eruptions
administration, oral
anticonvulsants
antipsychotic agents
drug hypersensitivity syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
guidelines for drug use

---
https://ansm.sante.fr/tableau-acces-derogatoire/crysvita
2023
false
false
false
France
French
drug information
burosumab
burosumab
FGF23-related hypophosphataemia
Oncogenic hypophosphatemic osteomalacia
hypophosphatemia

---
http://beh.santepubliquefrance.fr/beh/2023/12-13/2023_12-13_2.html
2023
France
journal article
inpatients
France
crisis, nos
Cancer
incidence
neoplasms
France
cancer
france
COVID-19
french
variant
France
has patient
France
neoplasm, malignant
hospital admission, nos
genetic variation
evaluation studies as topic

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/prolastinmc-c-liquid-deficit-congenital-en-alpha1-antitrypsine.html
2023
Canada
drug evaluation
alpha 1-Antitrypsin
prolastin
liquid substance, nos

---
https://www.ema.europa.eu/en/medicines/human/EPAR/opfolda
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
miglustat
miglustat
miglustat
drug approval
europe
adult
Glycogen storage disease due to acid maltase deficiency, late-onset
adult glycogen storage disease type II
drug therapy, combination
Cipaglucosidase Alfa
administration, oral
capsules
aged
food-drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://ansm.sante.fr/informations-de-securite/valproate-et-derives-risque-potentiel-de-troubles-neurodeveloppementaux-chez-les-enfants-dont-le-pere-a-ete-traite-dans-les-3-mois-qui-precedent-la-conception
2023
false
false
false
France
French
pharmacovigilance note
Divalproex Sodium
Neurodevelopmental Disorders
Male
risk
risk assessment
fathers
infant
child
Perinatal Exposure
paternal exposure
valproic acid
valproate sodium
teratogens

---
https://www.cochrane.org/fr/CD004197/CF_differentes-manieres-dadministrer-des-antibiotiques-pour-eliminer-une-infection-pseudomonas
2023
United Kingdom
review of literature
french abstract
organization and administration
cystic fibrosis
administration
pseudomonas aeruginosa
Administration
administration of antibiotic
Infectious disease
infection due to pseudomonas aeruginosa
Antibiotics
antibiotics
administrators
pseudomonas infections
mannerism
Cystic fibrosis
disease
cystic fibrosis
administrative personnel
anti-bacterial agents
persons
Pseudomonas aeruginosa Infection

---
https://www.has-sante.fr/jcms/p_3402366/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine
2023
false
false
false
France
vutrisiran
treatment outcome
insurance, health, reimbursement
Vutrisiran
rna, small interfering
injections, subcutaneous
adult
RNAi Therapeutics
amyloid neuropathies, familial
evaluation of the transparency committee
amyloidosis, hereditary, Transthyretin-Related

---
https://www.has-sante.fr/jcms/p_3455973/fr/strensiq-asfotase-alfa-hypophosphatasie
2023
false
false
false
France
hypophosphatasia
treatment outcome
insurance, health, reimbursement
enzyme replacement therapy
asfotase alfa
hypophosphatasia
evaluation of the transparency committee
asfotase alfa

---
https://www.has-sante.fr/jcms/p_3456306/fr/novoseven-eptacog-alfa-active-hemorragies-du-post-partum-severes
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
coagulation factor VIIa
recombinant FVIIa
injections, intravenous
evaluation of the transparency committee
eptacog alfa
postpartum hemorrhage

---
https://www.has-sante.fr/jcms/p_3456312/fr/ceprotin-proteine-c-humaine-deficit-congenital-severe-en-proteine-c
2023
false
false
false
France
protein C
treatment outcome
insurance, health, reimbursement
protein c
protein c deficiency
Coumarin necrosis (disorder)
purpura fulminans
venous thrombosis
evaluation of the transparency committee
protein c deficiency

---
https://www.has-sante.fr/jcms/p_3456518/fr/luxturna-voretigene-neparvovec-dystrophie-retinienne-hereditaire
2023
false
false
false
France
Voretigene Neparvovec
treatment outcome
insurance, health, reimbursement
gene therapy
biological products
adult
child
retinal dystrophies
Biallelic RPE65, retinoid isomerohydrolase mutation associated retinal dystrophy (disorder)
RPE65 gene mutation
adolescent
Subretinal Route of Administration
voretigene neparvovec
evaluation of the transparency committee
hereditary retinal dystrophy, nos
retinal dystrophies

---
https://www.has-sante.fr/jcms/p_3456825/fr/pombiliti-cipaglucosidase-alfa-opfolda-miglustat-en-association-forme-tardive-maladie-de-pompe
2023
false
false
false
France
Cipaglucosidase Alfa
cipaglucosidase alfa
Glycogen storage disease type II late onset (disorder)
miglustat
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
miglustat
drug therapy, combination
glycogen storage disease type ii

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/cartographie-optique-du-genome-diagnostic-et-stratification-pronostique-des-hemopathies-malignes.html
2023
Canada
technical report
genome mapping
chromosome mapping
hematologic diseases
Malignant hemopathy
hematologic neoplasms
genome, nos
Hematologic and hematopoietic diseases
Optics
no diagnosis
Hemopathies
diagnosis

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panels-des-cancers-pediatriques-par-sequencage-de-nouvelle-generation-de-lexome-et-du-transcriptome-somatiques.html
2023
Canada
review of literature
family characteristics
sequence determinations
sequence analysis
Pediatricians
generations
transcriptome
pediatrics
exome
pediatrician

---
https://cps.ca/fr/documents/position/la-pharmacotherapie-en-fonction-des-genes-chez-les-enfants
2023
false
false
false
false
false
Canada
pharmacogenetics
Drug-Related side effects and adverse reactions
practice guideline
child
genes

---
https://www.has-sante.fr/jcms/p_3431473/fr/deficits-immunitaires-hereditaires
2023
France
practice guideline
genetic diseases, inborn
Handbook
chronic disease
Diseases
hereditary disease, nos
Chronic disease
chronic disease, nos
Hereditary disease
immunologic deficiency syndromes
hereditary diseases

---
https://ansm.sante.fr/tableau-marr/patisiran
2023
false
false
false
France
French
risk management
patisiran
patisiran
guidelines for drug use
patisiran
infusions, intravenous
Drug-Related side effects and adverse reactions
patient education handout
Adverse reaction caused by drug or medicament administered by infusion (disorder)
Infusion Site Reaction
Infusion Site Reaction
signs and symptoms

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panels-des-predispositions-aux-cancers-pediatriques-par-sequencage-de-nouvelle-generation.html
2023
Canada
review of literature
pediatrician
family characteristics
generations
Pediatricians
pediatrics
disease susceptibility
sequence determinations
sequence analysis

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pathologie-pertinence-et-indications-de-transmission-selective-de-prelevements-chirurgicaux-au-laboratoire-danatomopathologie.html
2023
Canada
practice guideline
Drives
breeding
indication of
suggestive of
pathology, surgical
anatomic pathologist
indicators and reagents
laboratories

---
https://www.has-sante.fr/jcms/p_3460573/fr/kaftrio-ivacaftor-/-tezacaftor-/-elexacafto-en-association-avec-kalydeco-mucoviscidose-enfant-6-ans
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug therapy, combination
drug combinations
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor
ivacaftor
tezacaftor
guidelines for drug use
evaluation of the transparency committee
child
cystic fibrosis

---
https://ansm.sante.fr/actualites/topiramate-epitomax-et-generiques-et-troubles-neurodeveloppementaux-mise-en-place-de-mesures-en-europe-pour-limiter-lutilisation-pendant-la-grossesse
2023
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Topiramate
pregnancy
europe
Neurodevelopmental Disorders
risk
risk management
drug evaluation
Topiramate
france
anticonvulsants
anticonvulsants
anticonvulsants
Topiramate
topiramate
Female of Childbearing Potential

---
https://dumas.ccsd.cnrs.fr/dumas-04142148
2023
France
dissertations, academic
hereditary diseases
cardiomyopathies
hereditary disease, nos
metabolic disease, nos
dilated cardiomyopathy secondary to metabolic disorder
Metabolic Disorder
metabolic diseases
Genetic Disorder
Cardiomyopathy
metabolism, inborn errors

---
https://dumas.ccsd.cnrs.fr/dumas-04149147
2023
France
dissertations, academic
case management
disease
has patient
charge association
CHARGE Syndrome
Patient Load
Polycystic Ovary Syndrome
polycystic ovary syndrome
patient escort service
CHARGE syndrome
polycystic ovaries
Polycystic Ovary Syndrome

---
https://www.inserm.fr/dossier/hemochromatose-genetique/
2023
France
scientific and technical information
gene, nos
hemochromatosis
genetics
Hereditary Hemochromatosis
hemochromatosis, nos
Population Genetics
Cancer Genetics
Gene Therapy

---
https://ansm.sante.fr/informations-de-securite/lamotrigine-lamictal-et-generiques-rappel-du-bon-usage-afin-de-limiter-le-risque-deruption-cutanee-grave-en-particulier-au-debut-du-traitement
2023
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
Lamotrigine
Lamotrigine
risk management
lamotrigine
anticonvulsants
anticonvulsants
stevens-johnson syndrome
drug eruptions
Drug-Related side effects and adverse reactions
epidermal necrolysis, toxic
drug hypersensitivity syndrome
adult
child
drug interactions

---
https://anpgm.fr/media/documents/ANPGM_139_v3_Cancer_gastrique_diffus.pdf
2023
France
guideline
genetic predisposition
stomach, nos
genetic predisposition to disease
stomach neoplasms
Genetic Predisposition to Malignant Neoplasm
Genetic Predisposition to Cancer
genetics
neoplasm, malignant
Stomach
diffusion
Gastric Diffuse Adenocarcinoma
cancer of stomach

---
https://ansm.sante.fr/tableau-marr/lomitapide
2023
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral

---
https://ansm.sante.fr/informations-de-securite/prise-en-charge-par-colchicine-de-la-goutte-une-nouvelle-posologie-plus-faible-et-un-message-dalerte-sur-les-boites-pour-reduire-le-risque-de-surdosage
2023
false
false
false
France
French
risk management
colchicine
colchicine
gout
guidelines for drug use
gout suppressants
gout suppressants
colchicine

---
https://ansm.sante.fr/tableau-marr/imiglucerase
2023
false
false
false
France
French
guidelines for drug use
risk management
imiglucerase
imiglucerase
infusions, intravenous
enzyme replacement therapy
home nursing
gaucher disease
home infusion therapy
home infusion therapy

---
https://ansm.sante.fr/informations-de-securite/voxzogo-vosoritide-modification-de-la-seringue-et-de-laiguille-conduisant-a-une-administration-exprimee-en-unites-u-au-lieu-de-ml
2023
false
false
false
France
French
vosoritide
guidelines for drug use
Syringe markings confusion
risk

---
https://www.has-sante.fr/jcms/p_3467298/fr/nexviadyme-avalglucosidase-alfa-maladie-de-pompe
2023
false
false
false
France
enzyme replacement therapy
treatment outcome
insurance, health, reimbursement
avalglucosidase alfa
adult
adolescent
child
guidelines for drug use
infusions, intravenous
evaluation of the transparency committee
glycogen storage disease type ii
Avalglucosidase Alfa

---
https://www.cochrane.org/fr/CD015236/CF_prebiotiques-pour-les-personnes-atteintes-de-mucoviscidose
2023
United Kingdom
review of literature
french abstract
prebiotics
People
Cystic Fibrosis
cystic fibrosis
disease
persons
cystic fibrosis

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panel-pour-la-recherche-de-mutations-myeloides-par-sequencage-de-nouvelle-generation.html
2023
Canada
technical report
generations
Search
Next Generation Sequencing
Novel Mutation
mutation
Research
family characteristics
sequence analysis
research
Myeloid Mutation Panel
sequence determinations

---
https://www.has-sante.fr/jcms/p_3470456/fr/orkambi-lumacaftor/ivacaftor-mucoviscidose-enfant
2023
false
false
false
France
lumacaftor, ivacaftor drug combination
treatment outcome
insurance, health, reimbursement
ivacaftor
lumacaftor
drug combinations
administration, oral
ivacaftor and lumacaftor
Chloride Channel Agonists
cystic fibrosis
CFTR delta F508
guidelines for drug use
evaluation of the transparency committee
infant
cystic fibrosis

---
https://www.has-sante.fr/jcms/p_3470276/fr/pombiliti-cipaglucosidase-alfa-/-opfolda-miglustat-forme-tardive-de-la-maladie-de-pompe
2023
false
false
false
France
Glycogen storage disease type II late onset (disorder)
treatment outcome
insurance, health, reimbursement
drug therapy, combination
enzyme replacement therapy
adult
cipaglucosidase alfa
infusions, intravenous
administration, oral
miglustat
evaluation of the transparency committee
miglustat
glycogen storage disease type ii
Cipaglucosidase Alfa

---
https://dumas.ccsd.cnrs.fr/dumas-04213427
2023
France
dissertations, academic
Cannabidiol
pain, nos
CHARGE Syndrome
cannabidiol
charge association
Uncharged
Painful
cannabidiol
Chronic Graft Versus Host Disease
Placement
patient care management
Fula Language
CHARGE syndrome

---
https://www.has-sante.fr/jcms/p_3471037/fr/actualisation-2023-utilite-clinique-des-signatures-genomiques-dans-le-cancer-du-sein-rh-/her2-de-stade-precoce
2023
France
health technology assessment
neoplasm staging
Clinical Batch
Medical Examination
early
genome
breast cancer
Clinical Lot
technology assessment
genomics
Early Stage Breast Carcinoma
Genome
Clinical Data
hospitals, proprietary
health
Ambulatory Care Facility
Technology Assessment
neoplasm, malignant
genome, nos
technology assessment, biomedical
breast neoplasms
Signature
Useful

---
https://ansm.sante.fr/actualites/fibrinogene-humain-lansm-a-elabore-un-guide-pratique-pour-favoriser-le-bon-usage-des-produits-disponibles
2023
false
false
false
France
French
drug compounding
drug storage
guidelines for drug use
fibrinogen
human fibrinogen
Fibrinogen Human
Product containing only human fibrinogen (medicinal product)
fibrinogen

---
https://www.has-sante.fr/jcms/p_3478088/fr/galafold-chlorhydrate-de-migalastat-deficit-en-a-galactosidase-a
2023
false
false
false
France
fabry disease
adolescent
evaluation of the transparency committee
migalastat hydrochloride
migalastat
Migalastat Hydrochloride
galactosidases

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/principes-et-criteres-encadrant-le-recours-au-sequencage-pangenomique-en-trio-parents-enfant-en-genetique-constitutionnelle.html
2023
Canada
technical report
Child Relation
Nucleic Acid Sequencing
Population Genetics
Triple Functional Domain Protein
Gene Therapy
principle-based ethics
parents
Criterion
Cancer Genetics
sequence determinations
policy
Biopolymer Sequencing
Constitutional
gene, nos
TRIO Gene
child
genetics
Child Individual
child, nos
sequence analysis
parent, nos

---
https://www.has-sante.fr/jcms/p_3482344/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine
2023
false
false
false
France
RNAi Therapeutics
treatment outcome
insurance, health, reimbursement
vutrisiran
injections, subcutaneous
amyloid neuropathies, familial
adult
polyneuropathies
evaluation of the transparency committee
amyloidosis, hereditary, Transthyretin-Related
Vutrisiran

---
https://ansm.sante.fr/tableau-marr/avalglucosidase-alfa
2023
false
false
false
France
French
guidelines for drug use
risk management
Infusion-Related Reaction
medication errors
Avalglucosidase Alfa
infusions, intravenous
home infusion therapy
continuity of patient care
enzyme replacement therapy
GAA protein, human
avalglucosidase alfa
monitoring, immunologic
glycogen storage disease type ii

---
https://ansm.sante.fr/informations-de-securite/medicaments-contenant-du-topiramate-epitomax-et-generiques-modification-des-conditions-de-prescription-et-de-delivrance
https://ansm.sante.fr/actualites/topiramate-et-risques-chez-les-enfants-exposes-pendant-la-grossesse-modification-des-conditions-de-prescription-et-de-delivrance-aux-femmes-concernees-5
2023
false
false
false
France
French
abnormalities, drug-induced
Topiramate
Topiramate
teratogens
pregnancy
drug information
topiramate
risk
risk management
In Utero Drug Exposure
Neurodevelopmental Disorders
child

---
https://ansm.sante.fr/tableau-marr/volanesorsen
2023
false
false
false
France
French
guidelines for drug use
patients guideline
volanesorsen
thrombocytopenia
hemorrhage
familial hyperchylomicronemia syndrome
hyperlipoproteinemia type i
Drug-Related side effects and adverse reactions

---
https://www.inspq.qc.ca/publications/2887
2023
Canada
technical report
recessive hereditary disorder, nos
unilateral
Diseases
saints
judgment
persons
hereditary diseases
corpus callosum agenesis neuronopathy
ribs
Hereditary disease
genetic diseases, inborn

---
https://www.ceredih.fr/uploads/CEREDIH_RECO_ANTIBIO_2022_12_16.pdf
2023
France
scientific and technical information
amoxicillin-potassium clavulanate combination
Cefpodoxime
cefpodoxime
has patient
immunologic deficiency syndromes
France
bactrim
cefpodoxime
clamoxyl
France
France
patients
disease
clavulanic acid
france
augmentin
research report
french
albumin/globulin ratio
Cefpodoxime Proxetil
tension
France
amoxycillin with clavulanate potassium
Primary Immunodeficiency Diseases
amoxicillin
primary immune deficiency disorder, nos

---
https://www.anses.fr/fr/renforcer-surveillance-ogm-environnement
2023
France
popular works
Reinforcement, Psychology
Environment
reinforcement, nos
environmental monitoring
organisms, genetically modified

---
https://www.anses.fr/fr/system/files/BIOT2022SA0226.pdf
2023
France
technical report
spain
annual reports as topic
Genetics
albumin/globulin ratio
genets
genetics
Environment
comment
Annual Report
gene, nos
genetta, nos
environmental monitoring
inlets
Genetics
genista
aspartate aminotransferases
portugal
bays
Genetics
surveillance culture, nos

---
https://www.health.belgium.be/fr/avis-9414-besoins-nutritionnels-des-patients-souffrant-de-mucoviscidose
2023
Belgium
technical report
nutritional requirement
nutritional requirements
needs
cystic fibrosis
cystic fibrosis
patient need for
Cystic fibrosis
judgment
patients

---
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Patients-atteints-d-un-cancer-bronchique-non-a-petites-cellules-indications-des-tests-moleculaires-en-vue-de-la-prescription-de-traitements-de-precision
https://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Patients-atteints-d-un-cancer-bronchique-non-a-petites-cellules-indications-des-tests-moleculaires-en-vue-de-la-prescription-de-traitements-de-precision-Synthese
2023
false
false
false
France
molecular diagnostic techniques
practice guideline
patients
carcinoma, non-small-cell lung

---
https://www.has-sante.fr/jcms/p_3408892/fr/crysvita-burosumab-hypophosphatemie-liee-au-fgf23-chez-les-patients-ages-d-1-an-et-plus
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
burosumab
burosumab
injections, subcutaneous
infant
child
adolescent
adult
Phosphaturic Mesenchymal Tumor
oncogenic osteomalacia
hypophosphatemia
Fibroblast Growth Factor-23
FGF23-related hypophosphataemia
evaluation of the transparency committee

---
https://apps.who.int/iris/handle/10665/366031
2023
Switzerland
journal article
capacity building
genome, nos
epidemics
paraguay
untrained personnel
volunteers
Public health
public health
reinforcement, nos
health personnel
health education
brazil
medical laboratory personnel
laboratory personnel
genomics

---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-marion-fiorentino-robinson-gravier-dumonceau-mazelier
2023
France
audiovisual aids
Systematics
Africa
Systematic Review
Taxonomy
sex ratio
classification
Africa
men
Africa
Africa
Systematics
review literature as topic
Literature
africa
women
coitus
Africa
Africa
Systematics
sexual intercourse, nos

---
https://www.yearbook-ers.jle.com/e-docs/exposition_prenatale_aux_phtalates_vulnerabilite_genetique_via_le_stress_oxydant_et_developpement_neurologique_precoce_de_lenfant_332412/yb_breve.phtml
2022
France
journal article
genetics
Stress
Stress
Genetics
oxidation
Child development
stress, nos
child, nos
absence of stress
Genetics
Neurology
effects of exposure to external cause, nos
child, gifted
child development
Exhibition
Genetics
gene, nos
phthalic acids
neurology
Child development
oxidative stress

---
https://www.academie-medecine.fr/de-la-covid-19-a-la-variole-du-singe-variation-sur-le-theme-des-zoonoses/
2022
false
false
false
France
COVID-19
scientific and technical information
monkey, nos
smallpox
Zoonosis
smallpox, nos
Mpox (monkeypox)
zoonoses
genetic variation
zoonosis, nos
Smallpox
variant

---
https://www.has-sante.fr/jcms/p_3361535/fr/protopic-tacrolimus-monohydrate-dermatite-atopique-severe
2022
false
false
false
France
treatment outcome
dermatitis, atopic
tacrolimus
tacrolimus
administration, cutaneous
insurance, health, reimbursement
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3361556/fr/oxbryta-voxelotor-anemie-hemolytique-severe
2022
false
false
false
France
insurance, health, reimbursement
treatment outcome
voxelotor
administration, oral
hematologic agents
adult
adolescent
drug therapy, combination
hydroxyurea
evaluation of the transparency committee
Oxbryta
voxelotor
anemia, sickle cell

---
https://dumas.ccsd.cnrs.fr/dumas-03721336
2022
France
dissertations, academic
CHARGE syndrome
Child development
patient care management
speech therapy
gestures
persons with hearing impairments
Child development
speech therapy, nos
child, nos
child development
association

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panels-des-cancers-hereditaires-adultes-par-sequencage-de-nouvelle-generation.html
2022
Canada
review of literature
sequence determinations
sequence analysis
generations
adult
Adult
family characteristics
Adult
adulthood

---
https://www.has-sante.fr/jcms/p_3368156/fr/zokinvy-lonafarnib-syndrome-de-hutchinson-gilford
2022
false
false
false
France
progeria
treatment outcome
insurance, health, reimbursement
infant
child
Laminopathies
Laminopathies
mutation
LMNA Gene
zinc metallopeptidase STE24
guidelines for drug use
administration, oral
continuity of patient care
evaluation of the transparency committee
zokinvy
lonafarnib

---
https://apps.who.int/iris/handle/10665/363332
2022
Switzerland
journal article
Virus
sequence analysis
Viruses
Measles
measles virus
virus, nos
organization and administration
measles
measles virus
genotype
genotype
Drives
Off-Label use

---
https://www.has-sante.fr/jcms/p_3372074/fr/kalydeco-ivacaftor
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
adult
adolescent
child
cystic fibrosis
cystic fibrosis
mutation
infant
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance regulator gene
CFTR gene mutation
ivacaftor
evaluation of the transparency committee
ivacaftor

---
https://www.academie-medecine.fr/la-biologie-medicale-en-france-evolutions-et-enjeux/
2022
France
technical report
France
Biological evolution
france
biology
Biology
France
biological evolution
France
France
french

---
https://www.acadpharm.org/dos_public/RAPPORT_BIOLOGIE_MEDICALE_2022.10.05_VF.PDF
2022
false
false
false
France
French
technical report
France
France
France
France
Biology
biology
Biological evolution
france
french
biological evolution

---
https://www.has-sante.fr/jcms/p_3379875/fr/libmeldy-atidarsagene-autotemcel-leucodystrophie-metachromatique
2022
false
false
false
France
infusions, intravenous
Atidarsagene Autotemcel
leukodystrophy, metachromatic
metachromatic leukodystrophy, infant
leukodystrophy, metachromatic, juvenile
Biallelic Mutation
ARSA Gene
child
summary of product characteristics
package leaflet
immunotherapy, adoptive
guidelines for drug use
evaluation of the transparency committee

---
https://www.acadpharm.org/dos_public/RECOMMANDATIONS_ANP_ANM_BIOLOGIE_MEDICALE_3OCT22_CA_ANP_8_OCT_2022.PDF
2022
France
guideline
biological evolution
Biology
Biological evolution
biology

---
https://www.orpha.net/data/patho/Emg/Int/fr/CADASIL_FR_fr_EMG_ORPHA136.pdf
2022
France
practice guideline
CADASIL
best practices
snacks
Practice
emergencies

---
https://www.ema.europa.eu/en/medicines/human/EPAR/amvuttra
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Vutrisiran
Vutrisiran
orphan drug production
vutrisiran
amyloidosis, hereditary, Transthyretin-Related
adult
injections, subcutaneous
product surveillance, postmarketing
RNAi Therapeutics
pregnancy
breast feeding
rna, small interfering
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3385532/en/voxzogo-0-4-0-56-1-2-mg-vosoritide-achondroplasie
2022
false
false
false
France
treatment outcome
vosoritide
vosoritide
child
adolescent
achondroplasia
injections, subcutaneous
evaluation of the transparency committee

---
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-24-11-2022-pulmozyme-2500-u-2-5-ml-solution-pour-inhalation-par-nebuliseur
2022
false
false
false
France
French
drug information
legislation, pharmacy

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panel-des-rasopathies-par-sequencage-de-nouvelle-generation.html
2022
Canada
review of literature
generations
sequence analysis
sequence determinations
family characteristics

---
https://www.bag.admin.ch/bag/fr/home/medizin-und-forschung/genetische-untersuchungen/info-gentests.html
2022
France
popular works
Genetics
Human Genetics
gene, nos
Genetics
Genetics
genetta, nos
homo sapiens

---
https://www.anses.fr/fr/content/fig%C3%A9-fr%C3%A9quences-interm%C3%A9diaires-et-stress-g%C3%A9notoxique
2022
France
scientific and technical information
genotoxic stress
dna damage
Stress
absence of stress
stress, nos
Stress

---
https://www.has-sante.fr/jcms/p_3389365/fr/laminopathies-avec-presentation-cardiaque
2022
France
practice guideline
heart disease, nos
Handbook
chronic disease
Chronic disease
Laminopathies
heart diseases
chronic disease, nos
Diseases

---
https://www.has-sante.fr/jcms/p_3389587/fr/diabetes-monogeniques-de-type-mody
2022
France
practice guideline
Maturity onset diabetes of the young
Diseases
diabetes mellitus
chronic disease
maturity onset diabetes mellitus in young
chronic disease, nos
Handbook
Chronic disease
genetic diseases, inborn

---
https://www.has-sante.fr/jcms/p_3390116/fr/synaptopathie-due-aux-variations-pathogenes-du-gene-otof
2022
France
practice guideline
genetic variation
chronic disease
Chronic disease
gene, nos
Diseases
Embarrassment
Handbook
chronic disease, nos
genes
variant

---
https://publications.msss.gouv.qc.ca/msss/document-003517/
2022
Canada
public health guidelines
mass screening
guideline
nucleic acid amplification techniques
COVID-19
COVID-19 Testing
screening
leadership

---
https://www.has-sante.fr/jcms/p_3395907/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine
2022
false
false
false
France
Vutrisiran
treatment outcome
insurance, health, reimbursement
injections, subcutaneous
orphan drug production
polyneuropathies
vutrisiran
evaluation of the transparency committee
amyloidosis, hereditary, Transthyretin-Related

---
https://www.has-sante.fr/jcms/p_3398547/fr/upstaza-eladocagene-exuparvovec-maladie-rare
2022
false
false
false
France
evaluation of the transparency committee
rare diseases
Diseases
Rare disease
disease, nos

---
https://solidarites-sante.gouv.fr/IMG/pdf/dgs-urgent_no2023-01-_renforcement_surveillance_genomique_-_chine.pdf
2022
France
public health guidelines
organization and administration
china
Reinforcement, Psychology
genome, nos
genomics
SARS-CoV-2
reinforcement, nos

---
https://publications.msss.gouv.qc.ca/msss/document-003531/
2022
Canada
handbooks
Amino acid
amino acid, nos
Metabolic diseases
metabolic disease, nos
Hereditary disease
Metabolic diseases
waiting lists
hereditary disease, nos
hereditary diseases
Metabolic diseases
metabolism, inborn errors
amino acids
metabolic diseases
Diseases
Program

---
https://www.has-sante.fr/jcms/p_3402378/fr/upstaza-eladocagene-exuparvovec-deficit-en-decarboxylase-d-acide-l-amine-aromatique
2022
false
false
false
France
insurance, health, reimbursement
treatment outcome
child
infant
Eladocagene Exuparvovec
gene therapy
amino acid metabolism, inborn errors
Aromatic-L-Amino-Acid decarboxylases
infusions, parenteral
Intraputaminal Route of Administration
eladocagene exuparvovec
evaluation of the transparency committee
aromatic amino acid decarboxylase deficiency

---
https://www.ema.europa.eu/en/medicines/human/EPAR/upstaza
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Eladocagene Exuparvovec
aromatic amino acid decarboxylase deficiency
gene therapy
infant
child
drug approval
europe
amino acid metabolism, inborn errors
infusions, parenteral
Aromatic-L-Amino-Acid decarboxylases
orphan drug production
risk management
product surveillance, postmarketing
adolescent
adult
aromatic amino acid decarboxylase deficiency
genetic testing
Intraputaminal Route of Administration
eladocagene exuparvovec

---
https://www.calameo.com/onco-occitanie/read/00717809213a0fde7fc2c
2022
France
guideline
molecular biology
biology
Biology

---
https://dumas.ccsd.cnrs.fr/dumas-03978975
2022
France
dissertations, academic
prostheses and implants
microbiology
Microbiology
Technology
sequence determinations
Literature
Microbiology
review literature as topic
implant, nos
hospitals, university
microbiological techniques
sequence analysis
technology
hospitals, proprietary

---
https://dumas.ccsd.cnrs.fr/dumas-03946558
2022
France
Systematic Review
patella, nos
Psychology
psychology
Systematics
charge association
Systematics
psychological factors
CHARGE syndrome
classification
Systematics
postman
patellofemoral pain syndrome
CHARGE syndrome
patient care management
Taxonomy

---
https://ansm.sante.fr/actualites/essais-cliniques-de-medicaments-composes-dogm-nouvelles-modalites-de-depot-des-declarations-dutilisations-confinees
2022
false
false
false
France
French
legislation
organisms, genetically modified
clinical trials as topic

---
https://www.cochrane.org/fr/CD009595/CF_la-technique-de-respiration-par-drainage-autogene-pour-assister-les-personnes-atteintes-de
2022
false
false
false
United Kingdom
respiratory therapy
Autogenic pulmonary drainage (regime/therapy)
airway obstruction
review of literature
french abstract
cystic fibrosis

---
https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Biologie_medicale/INESSS_Panels_musculaires_SNG_EC.pdf
2022
false
false
false
Canada
technical report
nasogastric tube
family characteristics
Disease
disease, nos
muscular diseases
sequence analysis
muscle, nos
sequence determinations
generations
Diseases

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/detection-de-chlamydia-trachomatis-neisseria-gonorrhoeae-et-trichomonas-vaginalis-par-taan.html
2022
Canada
practice guideline
chlamydia trachomatis
neisseria gonorrhoeae
trichomonas vaginalis
neisseria gonorrhoeae
detective
nucleic acid amplification techniques
trichomonas vaginalis
chlamydia trachomatis

---
https://www.has-sante.fr/jcms/p_3313571/fr/voxzogo-vosoritide
2022
false
false
false
France
insurance, health, reimbursement
treatment outcome
vosoritide
achondroplasia
child, preschool
injections, subcutaneous
achondroplasia
evaluation of the transparency committee
vosoritide
Voxzogo

---
https://www.has-sante.fr/jcms/p_3312308/fr/aldurazyme-100-u/ml-laronidase
2022
false
false
false
France
insurance, health, reimbursement
enzyme replacement therapy
mucopolysaccharidosis I
hematopoietic stem cell transplantation
evaluation of the transparency committee

---
https://cps.ca/fr/documents/position/le-depistage-genetiques
2022
France
public health guidelines
genetic testing
gene, nos
child
child, nos
Child
Genetics
Child
Child
Genetics
genetta, nos
Child
Genetics

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/soutien-a-limplantation-des-analyses-effectuees-par-sequencage-de-nouvelle-generation-sng.html
2022
Canada
health technology assessment
prostheses and implants
family characteristics
nasogastric tube
implant, nos
sequence determinations
generations
sequence analysis

---
https://medicalforum.ch/fr/detail/doi/fms.2022.08858
2022
Switzerland
journal article
genetics, molecular
Pathology
prostatic neoplasms
gene, nos
neoplasm, malignant
Pathology
prostatism, nos
prostate, nos
Molecular genetics
Disorders
Prostate cancer
Pathology
Pathology
prostate cancer
Pathology
pathology, molecular
Pathology
Pathology
genetic diseases, inborn
Molecular genetics
malignant neoplasm prostate

---
https://publications.msss.gouv.qc.ca/msss/document-000201/
2022
Canada
handbooks
metabolism, inborn errors
Social Workers
Metabolic diseases
metabolic diseases
metabolic disease, nos
Metabolic diseases
Metabolic diseases
health facilities
Handbook
health services
Program
hereditary disease, nos
Diseases
social work
Hereditary disease
hereditary diseases
socialism

---
https://www.has-sante.fr/jcms/p_3322081/fr/lamictal-lamotrigine-epilepsies-partielles-et-generalisees
2022
France
evaluation of the transparency committee
epilepsy, generalized
Epilepsy
incomplete
Lamotrigine
Epilepsy
lamictal
generalized epilepsy, nos
lamotrigine
registries
epilepsies, partial

---
https://creaiors-occitanie.fr/bibliographie/prevenir-le-risque-prostitutionnel-et-les-conduites-preprostitutionnelles-des-mineur%c2%b7e%c2%b7s/
2022
false
false
false
false
France
bibliography
minors
bibliography
breeding
risk
risk-taking
Bibliographies as Topic

---
https://apps.who.int/iris/handle/10665/352604
2022
false
false
false
Switzerland
journal article
Preparation
blood group antigen yh a
blood group antigen le bh
genetta, nos
blood group antigen jn a
blood group antigen mo a
Genetics
virus, nos
cytisus
blood group antigen lw a
blood group antigen jc a
antigen, nos
blood group antigen le a
blood group antigen sw a
blood group antigen cr3
blood group antigen le s
blood group antigen jo a
blood group antigen a1 le d
blood group antigen kn a
blood group antigen gy a
blood group antigen sk a
Genetics
blood group antigen a3b
blood group antigen mcc a
pandemics
Viruses
blood group antigen ri a
blood group antigen to a
genets
blood group antigen u1a
Virus
blood group antigen tr a
blood group antigen a2b
blood group antigen co a
blood group antigen a1b
blood group antigen 'n'
Epidemiology
blood group antigen do a
blood group antigen pr a
blood group antigen le d
blood group antigen au a
blood group antigen lan
blood group antigen en akt
blood group antigen be a
blood group antigen le bl
blood group antigen jk a
epidemiology
blood group antigen cl a
Epidemiologists
blood group antigen wk a
blood group antigen sd a
blood group antigen c
blood group antigen ls a
blood group antigen fy a
genetics
blood group antigen dr a
blood group antigen vr
blood group antigen rd a
blood group antigen a.m.
blood group antigen go a
blood group antigen zt a
blood group antigen mi a
gene, nos
blood group antigen js a
blood group antigen jr a
blood group antigen rg a
Epidemiology
blood group antigen vg a
blood group antigen mt a
blood group antigen a x
blood group antigen pt a
blood group antigen ny a
Genetics
blood group antigen kp a
blood group antigen ol a
blood group antigen st a
blood group antigen m a
blood group antigen er a
blood group antigen nijhuis
blood group antigen le b
blood group antigen en afr
blood group antigen es a
blood group antigen ok a
Epidemiology
blood group antigen chr a
blood group antigen bg a
blood group antigen m'
blood group antigen an a
blood group antigen cs a
blood group antigen bx a
blood group antigen a1 le b
blood group antigen a3
blood group antigen wd a
blood group antigen lu a
blood group antigen at a
blood group antigen sc2
blood group antigen ch a
blood group antigen rb a
blood group antigen yt a
blood group antigen xg a
blood group antigen di a
due to
blood group antigen le x
blood group antigen bp a
blood group antigen je a
blood group antigen en ats
blood group antigen hg a
blood group antigen tg a
blood group antigen tj a
blood group antigen os a
blood group antigen en afs
blood group antigen dh a
blood group antigen in a
Epidemiology
antigens
blood group antigen n a
blood group antigen rh a
blood group antigen re a
blood group antigen pr a
blood group antigen th a
Antigens
blood group antigen ht a
blood group antigen li a
blood group antigen s1a
blood group antigen lw b
viverridae
viruses
blood group antigen a.m.
blood group antigen or a
blood group antigen rh42
blood group antigen yk a
blood group antigen a2
blood group antigen m1a
blood group antigen sf a
blood group antigen le ns
blood group antigen c
blood group antigen r1a
blood group antigen wr a
Epidemiology
blood group antigen fr a
blood group antigen le c

---
https://ansm.sante.fr/tableau-marr/velaglucerase-alfa
2022
false
false
false
France
French
risk management
velaglucerase alfa, human
Velaglucerase Alfa
Velaglucerase Alfa
guidelines for drug use
infusions, intravenous
drug hypersensitivity
infusions, intravenous
continuity of patient care
velaglucerase alfa
patients guideline
patient safety
enzyme replacement therapy
gaucher disease
Infusion-Related Reaction
home nursing

---
https://www.has-sante.fr/jcms/p_3327002/fr/kaftrio-ivacaftor-/-tezacaftor-/-elexacafto-en-association-avec-kalydeco-mucoviscidose
https://www.has-sante.fr/jcms/p_3327010/fr/decision-n-2022-0178/dp/sem-du-28-mars-2022-de-la-presidente-de-la-haute-autorite-de-sante-prise-au-nom-du-college-portant-autorisation-d-acces-precoce-de-la-specialite-kaftrio
2022
false
false
false
France
drug therapy, combination
drug combinations
administration, oral
ivacaftor, tezacaftor and elexacaftor
Product containing only elexacaftor and ivacaftor and tezacaftor in oral dose form (medicinal product form)
ivacaftor
tablets
legislation
guidelines for drug use
child
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor
ivacaftor
tezacaftor
cystic fibrosis with F508del mutation in the cystic fibrosis transmembrane conductance regulator gene
continuity of patient care
forms
professional role
evaluation of the transparency committee
cystic fibrosis

---
http://thesesante.ups-tlse.fr/3727/
2022
false
false
false
France
COVID-19
dissertations, academic
proxy
body weight
patient representatives
containment of biohazards
Periodical
patient advocacy
data collection
patient agent
genetic variation

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-dhyqviamc-immunoglobulines-humaines-normales-a-10-et-hyaluronidase-deficit-immunitaire-primaire-et-secondaire.html
2022
Canada
drug evaluation
has assessment
hyaluronoglucosaminidase
hyaluronoglucosaminidase
homo sapiens
principal
immunoglobulin A
Primary Immunodeficiency Diseases
immunoglobulin, nos
evaluation studies as topic
humans
immunologic deficiency syndromes
secondary immune deficiency disorder, nos

---
https://www.has-sante.fr/jcms/p_3332730/fr/octagam-immunoglobuline-humaine-normale-neuropathie-motrice-multifocale
2022
false
false
false
France
infusions, intravenous
treatment outcome
insurance, health, reimbursement
Multifocal motor neuropathy
polyneuropathies
adult
child
adolescent
immunologic factors
immunoglobulins, normal human, for intravascular adm.
evaluation of the transparency committee
immunoglobulins, intravenous

---
https://nuxeo.u-bourgogne.fr/nuxeo/site/esupversions/c5eed117-983a-49d9-96f2-91c03bb1caac
2022
false
false
false
France
dissertations, academic
cystic fibrosis
disease
evaluation studies as topic
child
enteral nutrition

---
https://www.yearbook-ers.jle.com/e-docs/exposition_prenatale_aux_substances_per_et_poly_fluoroalkylees_methylation_de_ladn_dans_le_sang_du_cordon_et_indicateurs_cardiometaboliques_chez_le_nouveau_ne_letude_healthy_start__322285/yb_breve.phtml
2022
false
false
false
France
journal article
Exhibition
dna methylation
cord blood
fetal blood
indicators and reagents
data collection
infant, newborn
indicators

---
https://ansm.sante.fr/actualites/mucoviscidose-de-nouveaux-patients-vont-pouvoir-beneficier-de-lassociation-des-medicaments-kaftrio-75-mg-50-mg-100-mg-et-kalydeco-150-mg
2022
false
false
false
France
French
cystic fibrosis
drug information

---
https://www.has-sante.fr/jcms/p_3343185/fr/kaftrio-elexacaftor/-ivacaftor/-tezacaftor-mucoviscidose
2022
false
false
false
France
French
evaluation of the transparency committee
tezacaftor
registries
cystic fibrosis
tezacaftor
Cystic fibrosis
cystic fibrosis

---
https://www.has-sante.fr/jcms/p_3343182/fr/kalydeco-ivacaftor-mucoviscidose-6-ans
2022
false
false
false
France
evaluation of the transparency committee
cystic fibrosis
Cystic fibrosis
ivacaftor
cystic fibrosis
traction
indication of
kalydeco
ivacaftor
ivacaftor
indicators
indicators and reagents

---
https://www.has-sante.fr/jcms/p_3348600/fr/oxbryta-voxelotor-carcinome-urothelial-anemie-hemolytique
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
voxelotor
drug therapy, combination
anemia, sickle cell
administration, oral
voxelotor
hydroxyurea
adult
adolescent
evaluation of the transparency committee
voxelotor

---
http://beh.santepubliquefrance.fr/beh/2022/14/2022_14_2.html
2022
France
journal article
Treatments
french
mortality
charge association
France
due to
france
CHARGE syndrome
Therapeutics
case management
acute coronary syndrome
France
CHARGE syndrome
high pitch
therapeutics
France
France
Acute coronary syndrome

---
https://ansm.sante.fr/actualites/valproate-et-derives-mise-a-jour-des-informations-sur-le-risque
2022
false
false
false
France
French
valproic acid
risk
pharmacovigilance note
valproic acid
pregnancy
abnormalities, drug-induced
eye abnormalities
risk assessment
dipropylacetamide
anticonvulsants
valproic acid
valpromide
valproate sodium
Divalproex Sodium

---
https://ansm.sante.fr/informations-de-securite/intoxications-graves-a-la-colchicine-colchicine-opocalcium-1-mg-et-colchimax-rappel-des-regles-de-bon-usage
2022
false
false
false
France
French
colchicine
administration, oral
pharmacovigilance note
guidelines for drug use
colchicine
gout suppressants
drug combinations
aged

---
https://www.paediatrieschweiz.ch/fr/immunodeficience-primaire-guide-pratique/
2022
Switzerland
journal article
pediatrician
principal
Pediatricians
Primary Immunodeficiency Diseases
immunodeficiency, nos
Practice
Handbook

---
https://apps.who.int/iris/handle/10665/358420
2022
Switzerland
journal article
poliovirus vaccine, oral
mars
Virus
Genetics
Genetics
mouth, nos
Viruses
preventive immunization/medication
Genetics
genetics
vaccinia virus
Vaccins
emergencies
vaccinia virus
vaccination
gene, nos
Vaccinia

---
https://www.afm-telethon.fr/fr/fiches-maladies/dystrophies-musculaires-congenitales
2022
France
popular works
muscular dystrophies
Muscular dystrophy
congenital dystrophy, nos
congenital muscular dysdrophy
muscular dystrophy, nos

---
https://www.afm-telethon.fr/fr/fiches-maladies/syndromes-myastheniques-congenitaux
2022
France
popular works
myasthenic syndromes, congenital
Myasthenia gravis

---
https://www.inserm.fr/actualite/sequencage-et-surveillance-genomique-des-virus-lumiere-sur-emergen-et-afroscreen/
2022
France
scientific and technical information
organization and administration
sequence determinations
viruses
light
sequence analysis
genome, nos
genome, viral
virus, nos
genomics
Viruses
Virus
light, nos

---
https://www.ema.europa.eu/en/medicines/human/EPAR/oxbryta
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
voxelotor
voxelotor
voxelotor
orphan drug production
anemia, sickle cell
Oxbryta
drug approval
europe
adolescent
adult
administration, oral
aged
hematologic agents
hematologic agents
product surveillance, postmarketing
pregnancy
breast feeding
drug therapy, combination
drug interactions
hemoglobin, sickle
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3356304/fr/detection-d-alterations-du-gene-ret-par-la-technique-de-sequencage-nouvelle-generation-ngs-cancer-bronchique-non-a-petites-cellules-et-cancer-medullaire-de-la-thyroide
2022
France
health technology assessment
thyroid neoplasms
thyroid cancer, medullary
Thyroid cancer
malignant neoplasm thyroid
neoplasm, malignant
Techniques
carcinoma, non-small-cell lung
detective
thyroid carcinoma
cells
bronchus, nos
"u" lymphocyte
Embarrassment
gene, nos
generations
sequence analysis
due to
Techniques
sequence determinations
bone marrow cells
Techniques
Techniques
Cell
family characteristics
thyroiditis, nos
genes

---
https://www.has-sante.fr/jcms/p_3352206/fr/glycerol/vaseline/paraffine-zydus-glycerol/-paraffine-liquide/-vaseline-secheresse-cutanee
2022
France
evaluation of the transparency committee
droughts
paraffin oils
paraffin, nos
petrolatum
petrolatum
registries
skin, nos
paraffin

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panels-des-maladies-cardiovasculaires-hereditaires-par-sequencage-de-nouvelle-generation-rapport-devaluation-sur-le-rapatriement-danalyses-realisees-hors-quebec.html
2022
Canada
technical report
disease of cardiovascular system, nos
Diseases
evaluation report
cardiovascular diseases
hereditary disease, nos
genetic diseases, inborn
family characteristics
sequence determinations
hereditary diseases
evaluation studies as topic
sequence analysis
Diseases of the cardiovascular system
Hereditary disease
albumin/globulin ratio
generations

---
https://www.has-sante.fr/jcms/p_3358109/fr/octagam-immunoglobuline-humaine-normale-dermatomyosite
2022
false
false
false
France
immunoglobulins, normal human, for intravascular adm.
insurance, health, reimbursement
treatment outcome
infusions, intravenous
immunologic factors
adult
drug therapy, combination
evaluation of the transparency committee
dermatomyositis
immunoglobulins, intravenous

---
https://www.has-sante.fr/jcms/p_3359159/fr/crysvita-burosumab-hypophosphatemie-liee-au-fgf23
https://www.has-sante.fr/jcms/p_3359197/fr/decision-n2022-0274/dc/sem-du-21-juillet-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-crysvita
2022
false
false
false
France
injections, subcutaneous
treatment outcome
insurance, health, reimbursement
child
adolescent
adult
Fibroblast Growth Factor-23
Phosphaturic Mesenchymal Tumor
oncogenic osteomalacia
guidelines for drug use
summary of product characteristics
package leaflet
burosumab
evaluation of the transparency committee
burosumab
hypophosphatemia

---
https://ansm.sante.fr/tableau-marr/hemine-humaine
2022
false
false
false
France
French
risk management
hemin
guidelines for drug use
continuity of patient care
infusions, intravenous
Drug-Related side effects and adverse reactions
Injection Site Reaction
hemin

---
https://www.ema.europa.eu/en/medicines/human/EPAR/nexviadyme
2022
false
false
false
Netherlands
French
drug approval
europe
avalglucosidase alfa
Avalglucosidase Alfa
Avalglucosidase Alfa
orphan drug production
glycogen storage disease type ii
drug evaluation
summary of product characteristics
syndication feed
package leaflet
enzyme replacement therapy
alpha-Glucosidases
infusions, intravenous
risk management
product surveillance, postmarketing
recombinant proteins
aged
pregnancy
drug evaluation, preclinical

---
https://www.cochrane.org/fr/CD008190/CF_stimulants-de-lappetit-pour-les-personnes-atteintes-de-mucoviscidose
2022
false
false
false
France
United Kingdom
French
meta-analysis
anorexia
treatment outcome
french abstract
appetite stimulants
cystic fibrosis

---
https://ansm.sante.fr/tableau-marr/hydroxycarbamide
2022
false
false
false
France
French
teratogens
hydroxyurea
hydroxyurea
continuity of patient care
guidelines for drug use
risk management
anemia, sickle cell
pain
adult
child
adolescent
fertility
pregnancy
contraception
blood cell count
hematologic diseases
patients guideline
package leaflet

---
https://www.cochrane.org/fr/CD012979/interventions-medicales-contre-linflammation-chronique-du-nez-et-des-sinus-chez-les-personnes
2022
false
false
false
France
United Kingdom
rhinitis
sinusitis
chronic disease
review of literature
french abstract
cystic fibrosis
chronic inflammation, nos

---
https://ansm.sante.fr/tableau-marr/acitretine
2021
false
false
false
France
French
guidelines for drug use
patients guideline
risk management
teratogens
continuity of patient care
acitretin
acitretin
pregnancy
contraception
administration, oral
acitretin
mental disorders
drug monitoring
Chemical and Drug Induced Liver Injury
pancreatitis
psoriasis

---
https://www.cochrane.org/fr/CD013079/CF_utilisation-de-traitements-antibiotiques-dans-les-infections-de-longue-duree-provoquees-par-les
2021
false
true
false
false
France
United Kingdom
burkholderia infections
aztreonam
review of literature
french abstract
cystic fibrosis
antibiotic therapy
anti-bacterial agents

---
https://www.inspq.qc.ca/publications/3032-personnes-gueries-nouveau-test-positif-covid19
2021
false
false
false
Canada
coronavirus infections
pneumonia, viral
quebec
Reinfection (qualifier value)
recurrence
nucleic acid amplification techniques
adaptive immunity
algorithms
patient isolation
review of literature
public health guidelines
patient care management
clinical laboratory techniques
pneumonia, viral
coronavirus infections
pandemics
pneumonia, viral
coronavirus infections
pandemics
COVID-19
COVID-19
COVID-19 Testing

---
https://www.cochrane.org/fr/CD003424/CF_medicaments-destines-reduire-lacidite-gastrique-chez-les-personnes-atteintes-de-mucoviscidose
2021
false
United Kingdom
France
French
review of literature
cystic fibrosis
treatment outcome
gastric acidity, nos
gastric acid
gastrointestinal agents
histamine h2 antagonists
proton pumps
french abstract

---
https://www.cochrane.org/fr/CD008901/CF_lutilisation-de-lhormone-de-croissance-recombinante-pour-ameliorer-la-croissance-et-la-sante-chez
2021
false
United Kingdom
France
French
review of literature
treatment outcome
cystic fibrosis
child
adolescent
young adult
human growth hormone
Recombinant Human Growth Hormone (Mammalian)
french abstract

---
https://www.medg.fr/albinisme
2021
France
teaching material
scientific and technical information
albinism, nos
albinism
Albinism

---
https://apps.who.int/iris/handle/10665/340335
2021
false
false
false
Switzerland
journal article
blood group antigen a1 le d
Antigens
blood group antigen sk a
blood group antigen vg a
blood group antigen vr
pandemics
blood group antigen a3
blood group antigen mo a
blood group antigen in a
viverridae
blood group antigen sf a
blood group antigen js a
blood group antigen en ats
blood group antigen rh a
Virus
blood group antigen le bh
blood group antigen a2
blood group antigen pr a
antigens
blood group antigen le a
blood group antigen th a
blood group antigen m'
blood group antigen le x
blood group antigen le c
blood group antigen cl a
blood group antigen dr a
blood group antigen pr a
blood group antigen hg a
blood group antigen bx a
blood group antigen jn a
blood group antigen le bl
genets
blood group antigen yt a
blood group antigen c
Viruses
Epidemiology
blood group antigen to a
blood group antigen wr a
Epidemiologists
blood group antigen sc2
blood group antigen 'n'
blood group antigen je a
genetics
blood group antigen tj a
blood group antigen bp a
blood group antigen le ns
blood group antigen a3b
blood group antigen rd a
blood group antigen or a
blood group antigen m1a
blood group antigen xg a
blood group antigen le s
blood group antigen kp a
Genetics
blood group antigen a1b
blood group antigen at a
Epidemiology
blood group antigen st a
blood group antigen a.m.
blood group antigen os a
blood group antigen r1a
Epidemiology
blood group antigen rh42
blood group antigen co a
gene, nos
blood group antigen lw b
blood group antigen au a
blood group antigen fr a
blood group antigen gy a
blood group antigen en afs
blood group antigen re a
blood group antigen ch a
virus, nos
blood group antigen cr3
blood group antigen yk a
blood group antigen cs a
blood group antigen en akt
blood group antigen fy a
blood group antigen n a
blood group antigen chr a
blood group antigen bg a
blood group antigen a x
blood group antigen pt a
Genetics
blood group antigen ny a
blood group antigen rg a
blood group antigen c
Epidemiology
blood group antigen a.m.
Preparation
blood group antigen ls a
blood group antigen sd a
epidemiology
blood group antigen kn a
blood group antigen do a
blood group antigen tr a
viruses
blood group antigen jc a
blood group antigen lw a
blood group antigen a1 le b
blood group antigen ri a
blood group antigen di a
blood group antigen ht a
blood group antigen jo a
blood group antigen ok a
blood group antigen mi a
blood group antigen wk a
blood group antigen sw a
blood group antigen go a
blood group antigen m a
blood group antigen yh a
blood group antigen wd a
blood group antigen mcc a
blood group antigen jk a
blood group antigen li a
blood group antigen le b
Epidemiology
blood group antigen a2b
blood group antigen dh a
blood group antigen en afr
blood group antigen nijhuis
antigen, nos
blood group antigen zt a
blood group antigen jr a
cytisus
blood group antigen s1a
blood group antigen be a
blood group antigen lan
blood group antigen mt a
genetta, nos
blood group antigen lu a
blood group antigen rb a
blood group antigen ol a
blood group antigen tg a
blood group antigen er a
Genetics
due to
blood group antigen an a
blood group antigen le d
blood group antigen u1a
blood group antigen es a

---
https://apps.who.int/iris/handle/10665/340698
2021
false
false
false
Switzerland
journal article
advisory committees
Epidemiology
Epidemiology
Epidemiologists
Influenza
sequence determinations
generations
viruses
Epidemiology
sequence analysis
family characteristics
Epidemiology
orientation
work
news
influenza
organization and administration
virus, nos
epidemiology
influenza, human
Labor ; manpower ; population
molecular typing
occupation, nos
world health organization
influenza, nos
detective
Epidemiology
Viruses
orientation, nos
Virus
group processes

---
https://apps.who.int/iris/handle/10665/347437
2021
false
false
false
Switzerland
journal article
blood group antigen ny a
Genetics
blood group antigen le s
blood group antigen rh a
blood group antigen ol a
Viruses
blood group antigen vg a
blood group antigen ok a
blood group antigen a1 le d
blood group antigen do a
blood group antigen sc2
blood group antigen nijhuis
blood group antigen bx a
blood group antigen jn a
blood group antigen bp a
blood group antigen mcc a
blood group antigen m'
blood group antigen n a
blood group antigen st a
blood group antigen c
blood group antigen en afs
Epidemiology
blood group antigen lan
blood group antigen le x
blood group antigen di a
blood group antigen jr a
blood group antigen le a
blood group antigen pr a
due to
blood group antigen js a
viruses
blood group antigen mi a
blood group antigen tj a
blood group antigen en ats
blood group antigen jc a
blood group antigen or a
Genetics
blood group antigen yk a
blood group antigen ht a
blood group antigen au a
pandemics
blood group antigen xg a
antigen, nos
blood group antigen r1a
blood group antigen re a
blood group antigen u1a
blood group antigen tg a
antigens
blood group antigen sd a
blood group antigen at a
blood group antigen tr a
blood group antigen zt a
genetics
blood group antigen chr a
blood group antigen ls a
blood group antigen lw b
genetta, nos
blood group antigen c
Antigens
gene, nos
blood group antigen co a
epidemiology
blood group antigen cl a
blood group antigen lu a
blood group antigen lw a
blood group antigen sw a
blood group antigen fy a
blood group antigen in a
blood group antigen a3b
blood group antigen le b
blood group antigen rd a
Epidemiology
blood group antigen en akt
blood group antigen to a
blood group antigen bg a
blood group antigen je a
blood group antigen es a
blood group antigen le bl
blood group antigen le c
blood group antigen a1 le b
blood group antigen en afr
blood group antigen a1b
blood group antigen 'n'
blood group antigen a.m.
blood group antigen os a
blood group antigen be a
viverridae
blood group antigen ri a
Epidemiology
blood group antigen a x
Epidemiology
blood group antigen jk a
blood group antigen m a
blood group antigen a.m.
blood group antigen jo a
Preparation
blood group antigen vr
blood group antigen an a
blood group antigen hg a
blood group antigen mo a
blood group antigen le d
blood group antigen rg a
cytisus
blood group antigen sk a
blood group antigen a2
blood group antigen kp a
blood group antigen sf a
blood group antigen cr3
blood group antigen wk a
blood group antigen pt a
genets
blood group antigen gy a
blood group antigen dh a
virus, nos
blood group antigen m1a
blood group antigen cs a
blood group antigen yt a
blood group antigen a3
blood group antigen dr a
blood group antigen mt a
blood group antigen wr a
blood group antigen wd a
blood group antigen a2b
blood group antigen le bh
blood group antigen th a
Virus
Epidemiology
blood group antigen le ns
blood group antigen rb a
blood group antigen er a
blood group antigen go a
blood group antigen rh42
blood group antigen fr a
blood group antigen kn a
blood group antigen yh a
Genetics
blood group antigen li a
blood group antigen pr a
blood group antigen s1a
Epidemiologists
blood group antigen ch a

---
Nous contacter.
07/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.